NMDAR2A anticorps (C-Term)
Aperçu rapide pour NMDAR2A anticorps (C-Term) (ABIN2140411)
Antigène
Voir toutes NMDAR2A (GRIN2A) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- NMDAR2A antibody was purified by affinity chromatography
-
Immunogène
- NMDAR2A antibody was raised in Rabbit using a synthetic peptide corresponding to a sequence at the C-terminal of human NMDAR2A, different from the related Rabbit sequence by three amino acids, and from the related rat sequences by four amino acids, as the immunogen
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal conditions to be determined by the end user
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- lyophilized form
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles
-
Stock
- -20 °C
-
Stockage commentaire
- Store at 4 °C for short term storage. For long term storage aliquot and store at -20 °C,
-
-
- NMDAR2A (GRIN2A) (Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2a (GRIN2A))
-
Autre désignation
- NMDAR2A
-
Pathways
- Synaptic Membrane, Regulation of long-term Neuronal Synaptic Plasticity
Antigène
-